Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vallerie V McLaughlin

Showing results (1-10 of 160) with videos related to

Pageof 16
Sort By:
Expert Opinion on Pharmacotherapy|February 7, 2002
Medical management of primary pulmonary hypertensionVallerie V McLaughlin
Cardiology Clinics|August 11, 2004
Classification and epidemiology of pulmonary hypertensionVallerie V McLaughlin
European Heart Journal|February 7, 2006
'Raising the bar' for the treatment of pulmonary arterial hypertensionVallerie V McLaughlin
Chest|December 5, 2012
Has the 6-min walk distance run its course?Vallerie V McLaughlin
Circulation|November 18, 2024
Pulmonary Hypertension: From Therapeutic Nihilism to Multiple Therapeutic InterventionsVallerie V McLaughlin, Marc Humbert
Circulation|November 5, 2003
Endothelin receptor blockers in cardiovascular diseaseStuart Rich, Vallerie V McLaughlin
Circulation|June 30, 2010
Prognosis of pulmonary arterial hypertension: the power of clinical registries of rare diseasesVallerie V McLaughlin, Samy Suissa
Chest|September 13, 2003
Successful management of pregnancy in a patient with eisenmenger syndrome with epoprostenolChris Geohas, Vallerie V McLaughlin
American Journal of Respiratory and Critical Care Medicine|June 5, 2007
Sickle cell disease-associated pulmonary hypertension: a coat of many colorsVallerie V McLaughlin, Richard Channick
Journal of the American College of Cardiology|June 27, 2009
The 4th World Symposium on Pulmonary Hypertension. IntroductionMarc Humbert, Vallerie V McLaughlin
Pageof 16

Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
Expert Opinion on Pharmacotherapy|February 7, 2002
Medical management of primary pulmonary hypertensionVallerie V McLaughlin
Cardiology Clinics|August 11, 2004
Classification and epidemiology of pulmonary hypertensionVallerie V McLaughlin
European Heart Journal|February 7, 2006
'Raising the bar' for the treatment of pulmonary arterial hypertensionVallerie V McLaughlin
Chest|December 5, 2012
Has the 6-min walk distance run its course?Vallerie V McLaughlin
Circulation|November 18, 2024
Pulmonary Hypertension: From Therapeutic Nihilism to Multiple Therapeutic InterventionsVallerie V McLaughlin, Marc Humbert
Circulation|November 5, 2003
Endothelin receptor blockers in cardiovascular diseaseStuart Rich, Vallerie V McLaughlin
Circulation|June 30, 2010
Prognosis of pulmonary arterial hypertension: the power of clinical registries of rare diseasesVallerie V McLaughlin, Samy Suissa
Chest|September 13, 2003
Successful management of pregnancy in a patient with eisenmenger syndrome with epoprostenolChris Geohas, Vallerie V McLaughlin
American Journal of Respiratory and Critical Care Medicine|June 5, 2007
Sickle cell disease-associated pulmonary hypertension: a coat of many colorsVallerie V McLaughlin, Richard Channick
Journal of the American College of Cardiology|June 27, 2009
The 4th World Symposium on Pulmonary Hypertension. IntroductionMarc Humbert, Vallerie V McLaughlin
Pageof 16